{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:42:59Z","timestamp":1793907779501,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diagnosing hypermobile Ehlers\u2013Danlos syndrome (hEDS) remains challenging, despite new 2017 criteria. Patients not fulfilling these criteria are considered to have hypermobile spectrum disorder (HSD). Our first aim was to evaluate whether patients hEDS were more severely affected and had higher prevalence of extra-articular manifestations than HSD. Second aim was to compare their outcome after coordinated physical therapy. Patients fulfilling hEDS\/HSD criteria were included in this real-life prospective cohort (November 2017\/April 2019). They completed a 16-item Clinical Severity Score (CSS-16). We recorded bone involvement, neuropathic pain (DN4) and symptoms of mast cell disorders (MCAS) as extra-articular manifestations. After a standardized initial evaluation (T0), all patients were offered the same coordinated physical therapy, were followed-up at 6\u00a0months (T1) and at least 1\u00a0year later (T2), and were asked whether or not their condition had subjectively improved at T2. We included 97 patients (61 hEDS, 36 HSD). Median age was 40 (range 18\u201373); 92.7% were females. Three items from CSS-16 (pain, motricity problems, and bleeding) were significantly more severe with hEDS than HSD. Bone fragility, neuropathic pain and MCAS were equally prevalent. At T2 (20\u00a0months [range 18\u201326]) 54% of patients reported improvement (no difference between groups). On multivariable analysis, only family history of hypermobility predicted (favorable) outcome (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01). hEDS and HDS patients showed similar disease severity score except for pain, motricity problems and bleeding, and similar spectrum of extra-articular manifestations. Long-term improvement was observed in\u2009&gt;\u200950% of patients in both groups. These results add weight to a clinical pragmatic proposition to consider hEDS\/HSD as a single entity that requires the same treatments.\n                  <\/jats:p>","DOI":"10.1007\/s00296-021-04968-3","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T10:04:07Z","timestamp":1629108247000},"page":"1785-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Are patients with hypermobile Ehlers\u2013Danlos syndrome or hypermobility spectrum disorder so different?"],"prefix":"10.1007","volume":"41","author":[{"given":"B\u00e9reng\u00e8re","family":"Aubry-Rozier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-1812","authenticated-orcid":false,"given":"Adrien","family":"Schwitzguebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Tanniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Paquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-7412","authenticated-orcid":false,"given":"Chantal","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-9581","authenticated-orcid":false,"given":"Thomas","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-0674","authenticated-orcid":false,"given":"Charles","family":"Benaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"4968_CR1","first-page":"804","volume":"34","author":"L Remvig","year":"2007","unstructured":"Remvig L, Jensen DV, Ward RC (2007) Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol 34:804\u2013809","journal-title":"J Rheumatol"},{"key":"4968_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jsams.2007.05.005","volume":"11","author":"CE Quatman","year":"2008","unstructured":"Quatman CE, Ford KR, Myer GD et al (2008) The effects of gender and pubertal status on generalized joint laxity in young athletes. J Sci Med Sport 11:257\u2013263. https:\/\/doi.org\/10.1016\/j.jsams.2007.05.005","journal-title":"J Sci Med Sport"},{"key":"4968_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ajmg.c.31429","volume":"169C","author":"M Colombi","year":"2015","unstructured":"Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome\/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet C Semin Med Genet 169C:6\u201322. https:\/\/doi.org\/10.1002\/ajmg.c.31429","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4968_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-94-007-7893-1_11","volume":"802","author":"M Mohamed","year":"2014","unstructured":"Mohamed M, Voet M, Gardeitchik T, Morava E (2014) Cutis Laxa. Adv Exp Med Biol 802:161\u2013184. https:\/\/doi.org\/10.1007\/978-94-007-7893-1_11","journal-title":"Adv Exp Med Biol"},{"key":"4968_CR5","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/ajmg.a.37365","volume":"167A","author":"L Bonafe","year":"2015","unstructured":"Bonafe L, Cormier-Daire V, Hall C et al (2015) Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 167A:2869\u20132892. https:\/\/doi.org\/10.1002\/ajmg.a.37365","journal-title":"Am J Med Genet A"},{"key":"4968_CR6","unstructured":"Aubry-Rozier B, Unger S, Bregou A, et al. [News in osteogenesis imperfecta: from research to clinical management]. Rev Med Suisse 2015;11:657\u20138, 60\u20132. - Search Results. In: PubMed. Accessed 2 Aug 2021"},{"key":"4968_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jbspin.2019.02.001","volume":"86","author":"M-H Lafage-Proust","year":"2019","unstructured":"Lafage-Proust M-H, Courtois I (2019) The management of osteogenesis imperfecta in adults: state of the art. Joint Bone Spine 86:589\u2013593. https:\/\/doi.org\/10.1016\/j.jbspin.2019.02.001","journal-title":"Joint Bone Spine"},{"key":"4968_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1589\/jpts.30.847","volume":"30","author":"B Corrado","year":"2018","unstructured":"Corrado B, Ciardi G (2018) Hypermobile Ehlers-Danlos syndrome and rehabilitation: taking stock of evidence based medicine: a systematic review of the literature. J Phys Ther Sci 30:843\u2013847. https:\/\/doi.org\/10.1589\/jpts.30.847","journal-title":"J Phys Ther Sci"},{"key":"4968_CR9","unstructured":"de Ferranti SD KE. Physical activity and exercise in patients with congenital heath disease, Literature review current through: Feb 2019. 2019;[cited 2019 Nov 10]. Available from: https:\/\/www.uptodate.com\/contents\/physical-activityand-exercise-in-pat - Search Results. In: PubMed. Accessed 2 Aug 2021"},{"key":"4968_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/fampra\/cmv026","volume":"32","author":"RH Terry","year":"2015","unstructured":"Terry RH, Palmer ST, Rimes KA et al (2015) Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract 32:354\u2013358. https:\/\/doi.org\/10.1093\/fampra\/cmv026","journal-title":"Fam Pract"},{"key":"4968_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P et al (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175:8\u201326. https:\/\/doi.org\/10.1002\/ajmg.c.31552","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4968_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1086\/376564","volume":"73","author":"MC Zweers","year":"2003","unstructured":"Zweers MC, Bristow J, Steijlen PM et al (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 73:214\u2013217. https:\/\/doi.org\/10.1086\/376564","journal-title":"Am J Hum Genet"},{"key":"4968_CR13","doi-asserted-by":"publisher","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","volume":"100","author":"R Morissette","year":"2015","unstructured":"Morissette R, Chen W, Perritt AF et al (2015) Broadening the spectrum of ehlers danlos syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 100:E1143-1152. https:\/\/doi.org\/10.1210\/jc.2015-2232","journal-title":"J Clin Endocrinol Metab"},{"key":"4968_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.semarthrit.2014.05.013","volume":"44","author":"I De Wandele","year":"2014","unstructured":"De Wandele I, Calders P, Peersman W et al (2014) Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum 44:353\u2013361. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.013","journal-title":"Semin Arthritis Rheum"},{"key":"4968_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajmg.c.31538","volume":"175","author":"B Tinkle","year":"2017","unstructured":"Tinkle B, Castori M, Berglund B et al (2017) Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet 175:48\u201369. https:\/\/doi.org\/10.1002\/ajmg.c.31538","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4968_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ajmg.a.61459","volume":"182","author":"L McGillis","year":"2020","unstructured":"McGillis L, Mittal N, Santa Mina D et al (2020) Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: a retrospective review. Am J Med Genet A 182:484\u2013492. https:\/\/doi.org\/10.1002\/ajmg.a.61459","journal-title":"Am J Med Genet A"},{"key":"4968_CR17","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/rheumatology\/kez029","volume":"58","author":"M Copetti","year":"2019","unstructured":"Copetti M, Morlino S, Colombi M et al (2019) Severity classes in adults with hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorders: a pilot study of 105 Italian patients. Rheumatology (Oxford) 58:1722\u20131730. https:\/\/doi.org\/10.1093\/rheumatology\/kez029","journal-title":"Rheumatology (Oxford)"},{"key":"4968_CR18","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00198-016-3562-2","volume":"27","author":"C Eller-Vainicher","year":"2016","unstructured":"Eller-Vainicher C, Bassotti A, Imeraj A et al (2016) Bone involvement in adult patients affected with Ehlers-Danlos syndrome. Osteoporos Int 27:2525\u20132531. https:\/\/doi.org\/10.1007\/s00198-016-3562-2","journal-title":"Osteoporos Int"},{"key":"4968_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1212\/WNL.0000000000002847","volume":"87","author":"D Cazzato","year":"2016","unstructured":"Cazzato D, Castori M, Lombardi R et al (2016) Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology 87:155\u2013159. https:\/\/doi.org\/10.1212\/WNL.0000000000002847","journal-title":"Neurology"},{"key":"4968_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/thoraxjnl-2016-209560","volume":"72","author":"T Gaisl","year":"2017","unstructured":"Gaisl T, Giunta C, Bratton DJ et al (2017) Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study. Thorax 72:729\u2013735. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209560","journal-title":"Thorax"},{"key":"4968_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ajmg.c.31555","volume":"175","author":"SL Seneviratne","year":"2017","unstructured":"Seneviratne SL, Maitland A, Afrin L (2017) Mast cell disorders in Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 175:226\u2013236. https:\/\/doi.org\/10.1002\/ajmg.c.31555","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4968_CR22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3122\/jabfm.2021.04.200374","volume":"34","author":"K Atwell","year":"2021","unstructured":"Atwell K, Michael W, Dubey J et al (2021) Diagnosis and management of hypermobility spectrum disorders in primary care. J Am Board Fam Med 34:838\u2013848. https:\/\/doi.org\/10.3122\/jabfm.2021.04.200374","journal-title":"J Am Board Fam Med"},{"key":"4968_CR23","first-page":"481","volume":"103","author":"KS Yew","year":"2021","unstructured":"Yew KS, Kamps-Schmitt KA, Borge R (2021) Hypermobile ehlers-danlos syndrome and hypermobility spectrum disorders. Am Fam Physician 103:481\u2013492","journal-title":"Am Fam Physician"},{"key":"4968_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2021.1933618","author":"SE Bennett","year":"2021","unstructured":"Bennett SE, Walsh N, Moss T, Palmer S (2021) Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory. Disabil Rehabil. https:\/\/doi.org\/10.1080\/09638288.2021.1933618","journal-title":"Disabil Rehabil"},{"key":"4968_CR25","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1002\/ajmg.a.61837","volume":"182","author":"JS Demes","year":"2020","unstructured":"Demes JS, McNair B, Taylor MRG (2020) Use of complementary therapies for chronic pain management in patients with reported Ehlers-Danlos syndrome or hypermobility spectrum disorders. Am J Med Genet A 182:2611\u20132623. https:\/\/doi.org\/10.1002\/ajmg.a.61837","journal-title":"Am J Med Genet A"},{"key":"4968_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24526","author":"S Vermeulen","year":"2020","unstructured":"Vermeulen S, De Mits S, De Ridder R et al (2020) Altered multi-segment ankle and foot kinematics during gait in patients with Hypermobile Ehlers-Danlos Syndrome\/Hypermobility spectrum disorder. A case-control study Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.24526","journal-title":"A case-control study Arthritis Care Res (Hoboken)"},{"key":"4968_CR27","doi-asserted-by":"crossref","unstructured":"Hamonet C BI, Pommeret St, Pommeret S, Amoretti R, Baeza-Velasco, Metlaine A. Ehlers-Danlos Syndrome type III (hypermobile)\u202f: clinical somatosensory scale (SSCS-62) validation, about 626 patients. . Bull Acad Natle M\u00e9d 2017;201:405\u201315. - Search Results. In: PubMed. Accessed 2 Aug 2021","DOI":"10.1016\/S0001-4079(19)30525-4"},{"key":"4968_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","volume":"114","author":"D Bouhassira","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29\u201336. https:\/\/doi.org\/10.1016\/j.pain.2004.12.010","journal-title":"Pain"},{"key":"4968_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/hae.13800","volume":"25","author":"R Jesudas","year":"2019","unstructured":"Jesudas R, Chaudhury A, Laukaitis CM (2019) An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population. Haemophilia 25:558\u2013566. https:\/\/doi.org\/10.1111\/hae.13800","journal-title":"Haemophilia"},{"key":"4968_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/MOP.0000000000000541","volume":"29","author":"M Castori","year":"2017","unstructured":"Castori M, Hakim A (2017) Contemporary approach to joint hypermobility and related disorders. Curr Opin Pediatr 29:640\u2013649. https:\/\/doi.org\/10.1097\/MOP.0000000000000541","journal-title":"Curr Opin Pediatr"},{"key":"4968_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6095","volume":"367","author":"AN Williams","year":"2019","unstructured":"Williams AN (2019) Ehlers-Danlos syndromes: new labels confuse everyone. BMJ 367:l6095. https:\/\/doi.org\/10.1136\/bmj.l6095","journal-title":"BMJ"},{"key":"4968_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0190-9622(87)70192-3","volume":"17","author":"M Kahana","year":"1987","unstructured":"Kahana M, Feinstein A, Tabachnic E et al (1987) Painful piezogenic pedal papules in patients with Ehlers-Danlos syndrome. J Am Acad Dermatol 17:205\u2013209. https:\/\/doi.org\/10.1016\/s0190-9622(87)70192-3","journal-title":"J Am Acad Dermatol"},{"key":"4968_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos"},{"key":"4968_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12020-018-1822-y","volume":"63","author":"AM Formenti","year":"2019","unstructured":"Formenti AM, Doga M, Frara S et al (2019) Skeletal fragility: an emerging complication of Ehlers-Danlos syndrome. Endocrine 63:225\u2013230. https:\/\/doi.org\/10.1007\/s12020-018-1822-y","journal-title":"Endocrine"},{"key":"4968_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00198-019-05269-z","volume":"31","author":"T Banica","year":"2020","unstructured":"Banica T, Coussens M, Verroken C et al (2020) Higher fracture prevalence and smaller bone size in patients with hEDS\/HSD-a prospective cohort study. Osteoporos Int 31:849\u2013856. https:\/\/doi.org\/10.1007\/s00198-019-05269-z","journal-title":"Osteoporos Int"},{"issue":"Suppl 107","key":"4968_CR36","first-page":"116","volume":"35","author":"D Syx","year":"2017","unstructured":"Syx D, De Wandele I, Rombaut L, Malfait F (2017) Hypermobility, the Ehlers-Danlos syndromes and chronic pain. Clin Exp Rheumatol 35(Suppl 107):116\u2013122","journal-title":"Clin Exp Rheumatol"},{"key":"4968_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-019-08755-8","volume":"58","author":"A Kohn","year":"2020","unstructured":"Kohn A, Chang C (2020) The relationship between hypermobile ehlers-danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS). Clin Rev Allergy Immunol 58:273\u2013297. https:\/\/doi.org\/10.1007\/s12016-019-08755-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"4968_CR38","first-page":"61","volume":"73","author":"S Daens","year":"2018","unstructured":"Daens S, Grossin D, Hermanns-L\u00ea T et al (2018) Severe Mast Cell Activation Syndrome in a 15-year-old patient with an hypermobile Ehlers-Danlos syndrome. Rev Med Liege 73:61\u201364","journal-title":"Rev Med Liege"},{"key":"4968_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/09638288.2017.1398278","volume":"41","author":"JV Simmonds","year":"2019","unstructured":"Simmonds JV, Herbland A, Hakim A et al (2019) Exercise beliefs and behaviours of individuals with Joint Hypermobility syndrome\/Ehlers-Danlos syndrome - hypermobility type. Disabil Rehabil 41:445\u2013455. https:\/\/doi.org\/10.1080\/09638288.2017.1398278","journal-title":"Disabil Rehabil"},{"key":"4968_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101508","volume":"34","author":"BT Tinkle","year":"2020","unstructured":"Tinkle BT (2020) Symptomatic joint hypermobility. Best Pract Res Clin Rheumatol 34:101508. https:\/\/doi.org\/10.1016\/j.berh.2020.101508","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4968_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/acr.24220","volume":"73","author":"M Coussens","year":"2021","unstructured":"Coussens M, Calders P, Lapauw B et al (2021) Does muscle strength change over time in patients with hypermobile ehlers-danlos syndrome\/hypermobility spectrum disorder? an eight-year follow-up study. Arthritis Care Res (Hoboken) 73:1041\u20131048. https:\/\/doi.org\/10.1002\/acr.24220","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4968_CR42","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.apmr.2016.02.015","volume":"97","author":"MC Scheper","year":"2016","unstructured":"Scheper MC, Juul-Kristensen B, Rombaut L et al (2016) Disability in adolescents and adults diagnosed with hypermobility-related disorders: a meta-analysis. Arch Phys Med Rehabil 97:2174\u20132187. https:\/\/doi.org\/10.1016\/j.apmr.2016.02.015","journal-title":"Arch Phys Med Rehabil"},{"key":"4968_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ajmg.c.31545","volume":"175","author":"RHH Engelbert","year":"2017","unstructured":"Engelbert RHH, Juul-Kristensen B, Pacey V et al (2017) The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome\/hypermobile Ehlers Danlos syndrome. Am J Med Genet C Semin Med Genet 175:158\u2013167. https:\/\/doi.org\/10.1002\/ajmg.c.31545","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4968_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/09638288.2017.1390695","volume":"41","author":"L Hope","year":"2019","unstructured":"Hope L, Juul-Kristensen B, L\u00f8vaas H et al (2019) Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome\/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study. Disabil Rehabil 41:333\u2013340. https:\/\/doi.org\/10.1080\/09638288.2017.1390695","journal-title":"Disabil Rehabil"},{"key":"4968_CR45","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/ajmg.a.36060","volume":"161A","author":"T Bathen","year":"2013","unstructured":"Bathen T, H\u00e5ngmann AB, Hoff M et al (2013) Multidisciplinary treatment of disability in ehlers-danlos syndrome hypermobility type\/hypermobility syndrome: A pilot study using a combination of physical and cognitive-behavioral therapy on 12 women. Am J Med Genet A 161A:3005\u20133011. https:\/\/doi.org\/10.1002\/ajmg.a.36060","journal-title":"Am J Med Genet A"},{"key":"4968_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031365","volume":"9","author":"JC Demmler","year":"2019","unstructured":"Demmler JC, Atkinson MD, Reinhold EJ et al (2019) Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison. BMJ Open 9:e031365. https:\/\/doi.org\/10.1136\/bmjopen-2019-031365","journal-title":"BMJ Open"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04968-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04968-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04968-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T20:30:07Z","timestamp":1630009807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04968-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4968"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04968-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B\u00e9reng\u00e8re Aubry-Rozier, Adrien Schwitzguebel, Flore Valerio, Joelle Tanniger, C\u00e9lia Paquier, Chantal Berna, Thomas Hugle and Charles Benaim declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}